151 related articles for article (PubMed ID: 28470620)
1. How to Determine Interdependencies of Glucose and Lactose Uptake Rates for Heterologous Protein Production with E. coli.
Wurm DJ; Herwig C; Spadiut O
Methods Mol Biol; 2017; 1586():397-408. PubMed ID: 28470620
[TBL] [Abstract][Full Text] [Related]
2. The E. coli pET expression system revisited-mechanistic correlation between glucose and lactose uptake.
Wurm DJ; Veiter L; Ulonska S; Eggenreich B; Herwig C; Spadiut O
Appl Microbiol Biotechnol; 2016 Oct; 100(20):8721-9. PubMed ID: 27229726
[TBL] [Abstract][Full Text] [Related]
3. E. coli HMS174(DE3) is a sustainable alternative to BL21(DE3).
Hausjell J; Weissensteiner J; Molitor C; Halbwirth H; Spadiut O
Microb Cell Fact; 2018 Oct; 17(1):169. PubMed ID: 30376846
[TBL] [Abstract][Full Text] [Related]
4. Lactose autoinduction with enzymatic glucose release: characterization of the cultivation system in bioreactor.
Mayer S; Junne S; Ukkonen K; Glazyrina J; Glauche F; Neubauer P; Vasala A
Protein Expr Purif; 2014 Feb; 94():67-72. PubMed ID: 24215862
[TBL] [Abstract][Full Text] [Related]
5. Lactose fed-batch overexpression of recombinant metalloproteins in Escherichia coli BL21 (DE3): process control yielding high levels of metal-incorporated, soluble protein.
Hoffman BJ; Broadwater JA; Johnson P; Harper J; Fox BG; Kenealy WR
Protein Expr Purif; 1995 Oct; 6(5):646-54. PubMed ID: 8535158
[TBL] [Abstract][Full Text] [Related]
6. Use of slow glucose feeding as supporting carbon source in lactose autoinduction medium improves the robustness of protein expression at different aeration conditions.
Ukkonen K; Mayer S; Vasala A; Neubauer P
Protein Expr Purif; 2013 Oct; 91(2):147-54. PubMed ID: 23938950
[TBL] [Abstract][Full Text] [Related]
7. Enhanced production of 2'-fucosyllactose in engineered Escherichia coli BL21star(DE3) by modulation of lactose metabolism and fucosyltransferase.
Chin YW; Kim JY; Lee WH; Seo JH
J Biotechnol; 2015 Sep; 210():107-15. PubMed ID: 26193630
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic platform knowledge of concomitant sugar uptake in Escherichia coli BL21(DE3) strains.
Wurm DJ; Hausjell J; Ulonska S; Herwig C; Spadiut O
Sci Rep; 2017 Mar; 7():45072. PubMed ID: 28332595
[TBL] [Abstract][Full Text] [Related]
9. On the expression of recombinant Cas9 protein in E. coli BL21(DE3) and BL21(DE3) Rosetta strains.
Carmignotto GP; Azzoni AR
J Biotechnol; 2019 Dec; 306():62-70. PubMed ID: 31545973
[TBL] [Abstract][Full Text] [Related]
10. Boosting Auto-Induction of Recombinant Proteins in Escherichia coli with Glucose and Lactose Additives.
Tahara N; Tachibana I; Takeo K; Yamashita S; Shimada A; Hashimoto M; Ohno S; Yokogawa T; Nakagawa T; Suzuki F; Ebihara A
Protein Pept Lett; 2021; 28(10):1180-1190. PubMed ID: 34353248
[TBL] [Abstract][Full Text] [Related]
11. Effect of postinduction nutrient feed composition and use of lactose as inducer during production of thermostable xylanase in Escherichia coli glucose-limited fed-batch cultivations.
Ramchuran SO; Holst O; Karlsson EN
J Biosci Bioeng; 2005 May; 99(5):477-84. PubMed ID: 16233820
[TBL] [Abstract][Full Text] [Related]
12. High Yield of Recombinant Protein in Shaken E. coli Cultures with Enzymatic Glucose Release Medium EnPresso B.
Ukkonen K; Neubauer A; Pereira VJ; Vasala A
Methods Mol Biol; 2017; 1586():127-137. PubMed ID: 28470602
[TBL] [Abstract][Full Text] [Related]
13. Novel escherichia coli strain allows efficient recombinant protein production using lactose as inducer.
Menzella HG; Ceccarelli EA; Gramajo HC
Biotechnol Bioeng; 2003 Jun; 82(7):809-17. PubMed ID: 12701147
[TBL] [Abstract][Full Text] [Related]
14. Lactose-induced production of human soluble B lymphocyte stimulator (hsBLyS) in E. coli with different culture strategies.
Li Z; Zhang X; Tan T
Biotechnol Lett; 2006 Apr; 28(7):477-83. PubMed ID: 16614929
[TBL] [Abstract][Full Text] [Related]
15. Efficient production of a thermophilic 2-deoxyribose-5-phosphate aldolase in glucose-limited fed-batch cultivations of Escherichia coli by continuous lactose induction strategy.
Pei XL; Wang QY; Li CL; Qiu XF; Xie KL; Huang LF; Wang AM; Zeng ZW; Xie T
Appl Biochem Biotechnol; 2011 Sep; 165(2):416-25. PubMed ID: 21509600
[TBL] [Abstract][Full Text] [Related]
16. Galactose can be an inducer for production of therapeutic proteins by auto-induction using E. coli BL21 strains.
Xu J; Banerjee A; Pan SH; Li ZJ
Protein Expr Purif; 2012 May; 83(1):30-6. PubMed ID: 22425658
[TBL] [Abstract][Full Text] [Related]
17. Enhanced production of human mini-proinsulin in fed-batch cultures at high cell density of Escherichia coli BL21(DE3)[pET-3aT2M2].
Shin CS; Hong MS; Bae CS; Lee J
Biotechnol Prog; 1997; 13(3):249-57. PubMed ID: 9190075
[TBL] [Abstract][Full Text] [Related]
18. Scale-up bioprocess development for production of the antibiotic valinomycin in Escherichia coli based on consistent fed-batch cultivations.
Li J; Jaitzig J; Lu P; Süssmuth RD; Neubauer P
Microb Cell Fact; 2015 Jun; 14():83. PubMed ID: 26063334
[TBL] [Abstract][Full Text] [Related]
19. Teaching an old pET new tricks: tuning of inclusion body formation and properties by a mixed feed system in E. coli.
Wurm DJ; Quehenberger J; Mildner J; Eggenreich B; Slouka C; Schwaighofer A; Wieland K; Lendl B; Rajamanickam V; Herwig C; Spadiut O
Appl Microbiol Biotechnol; 2018 Jan; 102(2):667-676. PubMed ID: 29159587
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of three industrial Escherichia coli strains in fed-batch cultivations during high-level SOD protein production.
Marisch K; Bayer K; Cserjan-Puschmann M; Luchner M; Striedner G
Microb Cell Fact; 2013 Jun; 12():58. PubMed ID: 23758670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
